🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at age 51 after a private battle with pancreatic malignancy.

“The shining star of our family has faded away for us in this life,” his relatives stated. “After a prolonged and brave battle with cancer, we are deeply saddened to declare that D’Angelo, recognized by his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on the music industry with his innovative modern soul style and collaborations with high-profile artists.

He launched his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The record achieved No. 4 on Billboard’s Top R&B Albums chart, went platinum soon after, and earned several award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that propelled his artistic journey into the limelight. The album premiered at No. 1 on both Billboard’s Top R&B Albums chart and the Billboard 200. He won two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a reluctant one, in the public consciousness. The intimate portrayal featured the artist, notably stripped down to his waist, performing directly into the camera.

D’Angelo retreated from the spotlight after releasing Voodoo and publicly struggled with substance abuse. In 2005, he was involved in a serious car crash that put him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with another top chart entry on the soul music rankings and a award for Top R&B Record.

Again, in his own mysterious way, D’Angelo had limited public outings in the subsequent period.

The singer was scheduled as a top act for the 2025 music event, but his appearance was called off, citing an “unexpected health issue.”

Although information is limited about D’Angelo’s health in the weeks before his death, he had apparently been hospitalized for an extended period and in hospice for two weeks.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic cancer, one of the most deadly and hardest to prevent forms of the disease, on a brilliant talent whose life was ended too soon.

“We are grieved that he can only leave dear memories with his loved ones, but we are eternally grateful for the heritage of extraordinarily moving songs he leaves behind,” his kin expressed.

Pancreatic Malignancy: Deadly and Difficult to Avoid

Pancreatic cancer affects the pancreas, a tiny gland that generates insulin and plays an essential role in digestion, among additional roles. The position and dimensions of the organ in the human system make it more challenging to identify cancer.

Even though pancreatic cancer accounts for only about 3% of malignancy cases annually in the United States, it is causes seven percent of malignancy fatalities.

Almost 70,000 people will be found to have pancreatic cancer and about fifty-two thousand will die of the illness in the year 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have few and ineffective therapies, and a narrow opportunity to make a significant difference on the well-being of people,” said a medical oncologist.

Because this disease seldom produces early symptoms, it’s frequently identified only once the condition is advanced. Even when a patient has indicators they are usually nonspecific and may be confused with a number of everyday ailments.

“Currently, there is no good way to detect this malignancy in the initial phases, except for listening to your body and consulting your physician if there are new or unusual symptoms,” said a medical director.

Frequent indicators of pancreatic cancer encompass:

• discomfort in the stomach or back
• weight loss
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At 51 years old, D’Angelo’s death is an outlier, as pancreatic cancer is most common in adults in the 65 to 75 age bracket. However, many cancers, such as this type, have become more common in younger people.

“Pancreatic cancer diagnosed before the age of 50 is considered rare, yet alarmingly, doctors are noticing a rising count of younger individuals affected by this condition,” said a specialist.

Family History Impacts Cancer Risk

In the absence of effective detection methods for pancreatic cancer, experts emphasized the importance of knowing your relatives’ health background. Certain risk factors, such as smoking and obesity also have an influence in the onset of pancreatic cancer.

Black individuals have the highest incidence of pancreatic cancer in the U.S. and are more prone to be found to have inoperable cancer.

“The first step toward lowering one’s risk of pancreatic cancer is assessing individual susceptibility. Individuals should review their genetic background, genetic background, and medical conditions, such as blood sugar disease, chronic pancreatitis, or obesity that may raise their susceptibility,” advised a medical professional.

Inherited genetic elements are associated with as much as ten percent of all this malignancy cases. If a relative in your family has had this disease, you may want to think about DNA analysis.

“For people with a family history of this condition or those having elevated risk genetic mutations, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to find initial alterations in the organ,” he clarified.

For those wishing to lower their chance, lifestyle changes may make a difference. The best action you can take to lower your risk of this disease is to stop tobacco use, and if you don’t smoke, avoid exposure altogether.

Heavy alcohol consumption is linked to pancreatitis, a risk factor for this malignancy, so limiting or abstaining from alcohol may help lower your chance.

Managing your weight or losing weight may also aid decrease your susceptibility. Individuals with obesity are 20% more likely to get this disease. This malignancy also is more frequent in those with diabetes, and weight loss can also reduce the risk of adult-onset diabetes.

Despite this disease’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and more recent combination chemotherapy. There are emerging targeted therapies that are already showing results,” remarked a expert.

For many individuals, however, education about this rare but {dev